{
    "2021-11-09": [
        [
            {
                "time": "",
                "original_text": "强者不再恒强，Q3医药也有“弟弟”",
                "features": {
                    "keywords": [
                        "强者",
                        "恒强",
                        "Q3",
                        "医药"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "云南白药“脱实向虚”投资“缩水”15亿，“百年老字号”应收增速过快有隐忧",
                "features": {
                    "keywords": [
                        "云南白药",
                        "脱实向虚",
                        "投资缩水",
                        "百年老字号",
                        "应收增速",
                        "隐忧"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}